Nu Skin Enterprises, Inc. (NUS)
NYSE: NUS · Real-Time Price · USD
5.33
+0.17 (3.29%)
At close: Aug 4, 2026, 4:00 PM EDT
5.45
+0.12 (2.25%)
Pre-market: Aug 5, 2026, 5:46 AM EDT
Nu Skin Enterprises Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,441 | 1,485 | 1,732 | 1,969 | 2,226 | 2,696 |
Revenue Growth | -14.17% | -14.26% | -12.04% | -11.53% | -17.44% | 4.41% |
Gross Profit Gross Profit Growth | 998.9 | 1,031 | 1,182 | 1,357 | 1,595 | 2,020 |
Operating Income Operating Income Growth | 79.69 | 65.76 | -151.59 | 48.27 | 110.85 | 233.99 |
Net Income Net Income Growth | 54.53 | 160.2 | -146.59 | 8.6 | 104.78 | 147.27 |
Earnings Per Share EPS Growth | 1.10 | 3.18 | -2.95 | 0.17 | 2.07 | 2.86 |
EPS Growth | - | - | - | -91.79% | -27.62% | -21.21% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Rhyz Investments - Manufacturing Rhyz Investments - Manufacturing Growth | 231.82 | 243.79 | 242.23 | 237.9 | 218.66 | 256.62 |
Nu Skin - Southeast Asia/Pacific Nu Skin - Southeast Asia/Pacific Growth | 203.1 | 209.8 | 244.85 | 267.21 | 344.41 | 336.65 |
Intersegment Intersegment Growth | -36.4 | -38 | -40.8 | -56.5 | -69.2 | -84.5 |
Rhyz Investments - Rhyz Other Rhyz Investments - Rhyz Other Growth | 18.61 | 17.79 | 85.19 | 35.21 | 3.83 | 0.44 |
Nu Skin - Japan Nu Skin - Japan Growth | 171.34 | 174.36 | 181.56 | 207.83 | 224.9 | 266.22 |
Nu Skin - South Korea Nu Skin - South Korea Growth | 123.03 | 130.22 | 163.71 | 236.1 | 268.71 | 354.25 |
Nu Skin - Mainland China Nu Skin - Mainland China Growth | 192.93 | 195.55 | 235.24 | 298.08 | 360.39 | 568.77 |
Nu Skin - Europe & Africa Nu Skin - Europe & Africa Growth | 148.35 | 150.15 | 164.16 | 192.35 | 204.28 | 283.2 |
Nu Skin - Americas Nu Skin - Americas Growth | 271.74 | 282.98 | 322.52 | 398.22 | 508.54 | 547.76 |
Nu Skin - Hong Kong/Taiwan Nu Skin - Hong Kong/Taiwan Growth | 116.39 | 117.38 | 130.61 | 153.59 | 157.2 | 162.61 |
Nu Skin - Other Nu Skin - Other Growth | 0.38 | 1.14 | 2.83 | -0.86 | 3.96 | 3.65 |
Total Total Growth | 1,441 | 1,485 | 1,732 | 1,969 | 2,226 | 2,696 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 200.41 | 239.84 | 197.99 | 267.82 | 278.51 | 354.81 |
Total Debt Total Debt Growth | 277.61 | 281.83 | 452.05 | 573.98 | 479.01 | 465.04 |
Net Cash (Debt) Net Cash Growth | -77.21 | -41.99 | -254.06 | -306.17 | -200.5 | -110.23 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.55 | -0.83 | -5.12 | -6.14 | -3.97 | -2.14 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 75.98 | 80.29 | 111.74 | 118.64 | 108.06 | 141.58 |
Capital Expenditures CapEx Growth | -34.41 | -34.28 | -41.58 | -58.49 | -59.06 | -68.62 |
Free Cash Flow Free Cash Flow Growth | 41.57 | 46.01 | 70.16 | 60.15 | 49.01 | 72.97 |
Free Cash Flow Growth | -36.94% | -34.42% | 16.64% | 22.74% | -32.84% | -76.86% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 69.31% | 69.45% | 68.23% | 68.93% | 71.65% | 74.95% |
Operating Margin | 5.53% | 4.43% | -8.75% | 2.45% | 4.98% | 8.68% |
Pretax Margin | 4.45% | 13.21% | -10.11% | 1.35% | 4.00% | 8.62% |
Profit Margin | 3.78% | 10.79% | -8.46% | 0.44% | 4.71% | 5.46% |
FCF Margin | 2.88% | 3.10% | 4.05% | 3.05% | 2.20% | 2.71% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.240 | 0.240 | 0.240 | 1.560 | 1.540 | 1.520 |
Dividend Per Share Growth | 0% | 0% | -84.61% | 1.30% | 1.32% | 1.33% |
Dividend Yield | 4.50% | 2.50% | 3.49% | 8.04% | 3.65% | 2.99% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 4.92 | 3.03 | - | 114.24 | 20.37 | 17.74 |
Forward PE | 4.85 | 7.29 | 8.13 | 9.99 | 15.49 | 12.91 |
P/FCF Ratio | 6.22 | 10.08 | 4.89 | 16.11 | 42.59 | 34.71 |
PS Ratio | 0.18 | 0.31 | 0.20 | 0.49 | 0.94 | 0.94 |